• Mashup Score: 0

    Collapse all Expand all Background Recurrent vulvovaginal candidiasis (RVVC) affects up to 5% of women. No comprehensive systematic review of treatments for RVVC has been published. Objectives The primary objective was to assess the effectiveness and safety of pharmacological and non‐pharmacological treatments for RVVC. The secondary objective was to assess patient preference of…

    Tweet Tweets with this article
    • The effectiveness & safety of treatments for recurrent vulvovaginal candidiasis https://t.co/f9ptZX5cVm "confidence in the evidence was low to very low due to serious concerns about risk of bias, unclear reporting & the limited number of studies that could be combined' #thrush